Table 3.
Outcomes | Difference in mean change (95% CI) | Between-group difference (95% CI) | ||
---|---|---|---|---|
WQXG | GEG | GEG vs. WQXG | P | |
SF-MPQ (0–45) | ||||
Week 12 | −9.8 (−11.9 to −7.6)∗ | −7.9 (−10.4 to −5.3)∗ | −1.7 (−3.5 to 0.01) | 0.051 |
Week 24 | −13.3 (−15.4 to −11.2)∗ | −11.4 (−13.9 to −8.9)∗ | −1.7 (−3.2 to −0.2)# | 0.032 |
| ||||
VAS (0–10) | ||||
Week 12 | −2.5 (−3.2 to −3.8)∗ | −1.9 (−2.8 to −1.0∗ | −0.3 (−1.0 to 0.4) | 0.357 |
Week 24 | −4.0 (−4.7 to −3.4)∗ | −2.8 (−3.8 to −1.9)∗ | −0.9 (−1.8 to −0.1)# | 0.035 |
| ||||
PPI (0–5) | ||||
Week 12 | −1.4 (−1.8 to −1.0)∗ | −1.2 (−1.7 to −0.7)∗ | −0.3 (−0.7 to 0.1) | 0.166 |
Week 24 | −2.1 (−2.5 to −1.7)∗ | −1.6 (−2.1 to −1.1)∗ | −0.6 (−1.0 to −0.1)# | 0.014 |
The pain intensity was assessed by SF-MPQ, and VAS and PPI as subtables were used for further evaluation. The changes in mean were calculated from the difference between the current value and the baseline data. Compared with baseline, ∗P < 0.05; compared with the GEG at the same time point, #P < 0.05. CI, confidence interval; WQXG, Wuqinxi group; GEG: general exercise group; SF-MPQ: Short-Form McGill Pain Questionnaire; VAS: Visual Analog Scale; PPI: Present Pain Intensity.